Study summary

An old heart drug, digitoxin, lowered death or hospital stays

DIGIT-HF trial (digitoxin) · 1,212 people, randomized trial · Published August 2025, New England Journal of Medicine

39.5%died or were hospitalized for heart failure, vs 44.1% with placebo

What was tested

Digitoxin, a digitalis drug, or placebo added to modern treatment in heart failure with reduced ejection fraction and significant symptoms.

What they found

What it means

A cheap, once-daily add-on for people still symptomatic on standard drugs.

N Engl J Med, via PubMed ↗ ← Back to the outlook
Last reviewed 2026-11-16 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.